Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: The PEMVITASTART randomized trial

Navneet Singh; Milind Baldi; Jyotdeep Kaur; Valliappan Muthu; Kuruswamy T. Prasad; Digambar Behera; Amanjit Bal; Nalini Gupta; Rakesh Kapoor

doi:10.1002/cncr.32028

Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: The PEMVITASTART randomized trial

Cancer ◽

10.1002/cncr.32028 ◽

2019 ◽

Vol 125 (13) ◽

pp. 2203-2212 ◽

Cited By ~ 1

Author(s):

Navneet Singh ◽

Milind Baldi ◽

Jyotdeep Kaur ◽

Valliappan Muthu ◽

Kuruswamy T. Prasad ◽

...

Keyword(s):

Lung Cancer ◽

Folic Acid ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Hematologic Toxicity ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Vitamin B12 Supplementation ◽

First Line Treatment

Download Full-text

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Case Medical Research ◽

10.31525/ct1-nct03890055 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)

Case Medical Research ◽

10.31525/ct1-nct04009317 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

First Line Treatment

Download Full-text

Phase I Study of Apatinib in Combination with Gefitinib As First-Line Treatment in Patients with EGFR-Mutant Advanced Non-Squamous Non-Small Cell Lung Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3454715 ◽

2019 ◽

Author(s):

Zhonghan Zhang ◽

Yang Zhang ◽

Fan Luo ◽

Yuxiang Ma ◽

Wenfeng Fang ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Phase I Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2021.04.057 ◽

2021 ◽

Vol 69 ◽

pp. S36

Author(s):

Y. Belaroussi ◽

S. Cousin ◽

M. Carton ◽

M. Lebitasy ◽

L. Laborde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer

Thoracic Cancer ◽

10.1111/1759-7714.13462 ◽

2020 ◽

Author(s):

Po‐Lan Su ◽

Chian‐Wei Chen ◽

Yi‐Lin Wu ◽

Chien‐Chung Lin ◽

Wu‐Chou Su

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

P48.09 Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.879 ◽

2021 ◽

Vol 16 (3) ◽

pp. S503

Author(s):

B. Han ◽

W. Zhang ◽

B. Zhang ◽

Y. Chen ◽

Y. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants

Cancer Medicine ◽

10.1002/cam4.2984 ◽

2020 ◽

Vol 9 (10) ◽

pp. 3328-3336 ◽

Cited By ~ 3

Author(s):

Haiyan Xu ◽

Quan Zhang ◽

Li Liang ◽

Junling Li ◽

Zhefeng Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy ◽

First Line Treatment

Download Full-text

Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2019.12.57 ◽

2019 ◽

Vol 8 (8) ◽

pp. E11-E14

Author(s):

Teppei Yamaguchi ◽

Toyoaki Hida

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Doublet Versus Single Cytotoxic Agent as First-Line Treatment for Elderly Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Lung ◽

10.1007/s00408-012-9399-3 ◽

2012 ◽

Vol 190 (5) ◽

pp. 477-485 ◽

Cited By ~ 23

Author(s):

Wei-Xiang Qi ◽

Li-na Tang ◽

Ai-na He ◽

Zan Shen ◽

Feng Lin ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

Expert Review of Anticancer Therapy ◽

10.1586/era.09.3 ◽

2009 ◽

Vol 9 (4) ◽

pp. 425-435 ◽

Cited By ~ 19

Author(s):

Marcello Tiseo ◽

Marco Bartolotti ◽

Francesco Gelsomino ◽

Andrea Ardizzoni

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Histologic Subtype ◽

First Line Treatment

Download Full-text